Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?

Neurosurgery. 2008 Aug;63(2):N8. doi: 10.1227/01.NEU.0000335796.72760.EC.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Humans
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Receptors, Interleukin-6 / physiology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab